ASX - By Stock
|
AN1 |
Re:
Ann: Appendix 4C and Quarterly Activity Report
|
|
micc
|
105 |
23K |
4 |
03/08/21 |
03/08/21 |
ASX - By Stock
|
105
|
23K
|
4
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Appendix 4D and Half Year Report
|
|
micc
|
48 |
8.3K |
10 |
19/02/21 |
19/02/21 |
ASX - By Stock
|
48
|
8.3K
|
10
|
|
ASX - By Stock
|
AN1 |
"Target Corona (COVID19) - Midkine is where the fire is coming from"
|
|
micc
|
7 |
2.2K |
14 |
31/07/20 |
31/07/20 |
ASX - By Stock
|
7
|
2.2K
|
14
|
|
ASX - By Stock
|
AN1 |
Re:
UK approves European made antibody test
|
|
micc
|
15 |
3.7K |
5 |
30/04/20 |
30/04/20 |
ASX - By Stock
|
15
|
3.7K
|
5
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
micc
|
1.2K |
407K |
9 |
25/04/20 |
25/04/20 |
ASX - By Stock
|
1.2K
|
407K
|
9
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
micc
|
1.2K |
407K |
17 |
25/04/20 |
25/04/20 |
ASX - By Stock
|
1.2K
|
407K
|
17
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Independent Test Results For The Wondfo SARS-CoV-2 Test
|
|
micc
|
145 |
33K |
1 |
23/04/20 |
23/04/20 |
ASX - By Stock
|
145
|
33K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Independent Test Results For The Wondfo SARS-CoV-2 Test
|
|
micc
|
145 |
33K |
2 |
23/04/20 |
23/04/20 |
ASX - By Stock
|
145
|
33K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Independent Test Results For The Wondfo SARS-CoV-2 Test
|
|
micc
|
145 |
33K |
0 |
23/04/20 |
23/04/20 |
ASX - By Stock
|
145
|
33K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Independent Test Results For The Wondfo SARS-CoV-2 Test
|
|
micc
|
145 |
33K |
0 |
23/04/20 |
23/04/20 |
ASX - By Stock
|
145
|
33K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Independent Test Results For The Wondfo SARS-CoV-2 Test
|
|
micc
|
145 |
33K |
1 |
23/04/20 |
23/04/20 |
ASX - By Stock
|
145
|
33K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Independent Test Results For The Wondfo SARS-CoV-2 Test
|
|
micc
|
145 |
33K |
0 |
23/04/20 |
23/04/20 |
ASX - By Stock
|
145
|
33K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Independent Test Results For The Wondfo SARS-CoV-2 Test
|
|
micc
|
145 |
33K |
7 |
23/04/20 |
23/04/20 |
ASX - By Stock
|
145
|
33K
|
7
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Independent Test Results For The Wondfo SARS-CoV-2 Test
|
|
micc
|
145 |
33K |
18 |
23/04/20 |
23/04/20 |
ASX - By Stock
|
145
|
33K
|
18
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Independent Test Results For The Wondfo SARS-CoV-2 Test
|
|
micc
|
145 |
33K |
27 |
22/04/20 |
22/04/20 |
ASX - By Stock
|
145
|
33K
|
27
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received
|
|
micc
|
394 |
121K |
5 |
18/04/20 |
18/04/20 |
ASX - By Stock
|
394
|
121K
|
5
|
|
ASX - By Stock
|
AN1 |
Re:
How does CDY compare to AT1?
|
|
micc
|
2 |
1.3K |
5 |
18/04/20 |
18/04/20 |
ASX - By Stock
|
2
|
1.3K
|
5
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received
|
|
micc
|
394 |
121K |
6 |
17/04/20 |
17/04/20 |
ASX - By Stock
|
394
|
121K
|
6
|
|
ASX - By Stock
|
AN1 |
Re:
Tomorrows Chart
|
|
micc
|
32 |
9.6K |
5 |
16/04/20 |
16/04/20 |
ASX - By Stock
|
32
|
9.6K
|
5
|
|
ASX - By Stock
|
AN1 |
Re:
Tomorrows Chart
|
|
micc
|
32 |
9.6K |
2 |
16/04/20 |
16/04/20 |
ASX - By Stock
|
32
|
9.6K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Proposed issue of Securities - CDY
|
|
micc
|
56 |
13K |
1 |
16/04/20 |
16/04/20 |
ASX - By Stock
|
56
|
13K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received
|
|
micc
|
394 |
121K |
4 |
16/04/20 |
16/04/20 |
ASX - By Stock
|
394
|
121K
|
4
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received
|
|
micc
|
394 |
121K |
14 |
16/04/20 |
16/04/20 |
ASX - By Stock
|
394
|
121K
|
14
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Proposed issue of Securities - CDY
|
|
micc
|
56 |
13K |
0 |
16/04/20 |
16/04/20 |
ASX - By Stock
|
56
|
13K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received
|
|
micc
|
394 |
121K |
2 |
16/04/20 |
16/04/20 |
ASX - By Stock
|
394
|
121K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received
|
|
micc
|
394 |
121K |
3 |
15/04/20 |
15/04/20 |
ASX - By Stock
|
394
|
121K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received
|
|
micc
|
394 |
121K |
4 |
15/04/20 |
15/04/20 |
ASX - By Stock
|
394
|
121K
|
4
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received
|
|
micc
|
394 |
121K |
1 |
15/04/20 |
15/04/20 |
ASX - By Stock
|
394
|
121K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received
|
|
micc
|
394 |
121K |
0 |
15/04/20 |
15/04/20 |
ASX - By Stock
|
394
|
121K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received
|
|
micc
|
394 |
121K |
3 |
15/04/20 |
15/04/20 |
ASX - By Stock
|
394
|
121K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received
|
|
micc
|
394 |
121K |
12 |
15/04/20 |
15/04/20 |
ASX - By Stock
|
394
|
121K
|
12
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received
|
|
micc
|
394 |
121K |
1 |
14/04/20 |
14/04/20 |
ASX - By Stock
|
394
|
121K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
micc
|
1.2K |
407K |
12 |
10/04/20 |
10/04/20 |
ASX - By Stock
|
1.2K
|
407K
|
12
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
micc
|
1.2K |
407K |
1 |
07/04/20 |
07/04/20 |
ASX - By Stock
|
1.2K
|
407K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
micc
|
1.2K |
407K |
17 |
07/04/20 |
07/04/20 |
ASX - By Stock
|
1.2K
|
407K
|
17
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Suspension from Official Quotation
|
|
micc
|
94 |
28K |
0 |
06/04/20 |
06/04/20 |
ASX - By Stock
|
94
|
28K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Suspension from Official Quotation
|
|
micc
|
94 |
28K |
4 |
06/04/20 |
06/04/20 |
ASX - By Stock
|
94
|
28K
|
4
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Suspension from Official Quotation
|
|
micc
|
94 |
28K |
4 |
06/04/20 |
06/04/20 |
ASX - By Stock
|
94
|
28K
|
4
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Suspension from Official Quotation
|
|
micc
|
94 |
28K |
7 |
06/04/20 |
06/04/20 |
ASX - By Stock
|
94
|
28K
|
7
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Trading Halt
|
|
micc
|
463 |
149K |
0 |
04/04/20 |
04/04/20 |
ASX - By Stock
|
463
|
149K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Trading Halt
|
|
micc
|
463 |
149K |
2 |
04/04/20 |
04/04/20 |
ASX - By Stock
|
463
|
149K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Trading Halt
|
|
micc
|
463 |
149K |
6 |
04/04/20 |
04/04/20 |
ASX - By Stock
|
463
|
149K
|
6
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Trading Halt
|
|
micc
|
463 |
149K |
2 |
03/04/20 |
03/04/20 |
ASX - By Stock
|
463
|
149K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Trading Halt
|
|
micc
|
463 |
149K |
3 |
02/04/20 |
02/04/20 |
ASX - By Stock
|
463
|
149K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Trading Halt
|
|
micc
|
463 |
149K |
3 |
02/04/20 |
02/04/20 |
ASX - By Stock
|
463
|
149K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Trading Halt
|
|
micc
|
463 |
149K |
4 |
02/04/20 |
02/04/20 |
ASX - By Stock
|
463
|
149K
|
4
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Trading Halt
|
|
micc
|
463 |
149K |
0 |
02/04/20 |
02/04/20 |
ASX - By Stock
|
463
|
149K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
pop-up COVID19 testing
|
|
micc
|
118 |
26K |
3 |
01/04/20 |
01/04/20 |
ASX - By Stock
|
118
|
26K
|
3
|
|
ASX - Day Trading
|
|
Re:
Afternoon trading April 1
|
|
micc
|
265 |
56K |
3 |
01/04/20 |
01/04/20 |
ASX - Day Trading
|
265
|
56K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
micc
|
1.2K |
407K |
0 |
01/04/20 |
01/04/20 |
ASX - By Stock
|
1.2K
|
407K
|
0
|
|